Jonathan Lovell

PhD

UB Distinguished Professor

Nanomedicine; phototherapy

Buffalo NY, 14260

Phone: (716) 645-1020

Fax: (716) 645-2207

Study: 3-in-1 vaccine shows promise against 'tripledemic'
7/6/26
Niagara Frontier Publications highlighted research, led by Jonathan Lovell, to develop a single-shot vaccine that could protect against flu, COVID-19 and RSV simultaneously.
Study: Three-in-one vaccine shows promise against ‘tripledemic’
6/26/26
UB researchers, led by Jonathan Lovell, are developing a single-shot vaccine that could protect against flu, COVID-19 and RSV simultaneously.
Study: Three-in-one vaccine shows promise against ‘tripledemic’
6/26/26
University at Buffalo researchers are developing a single shot for flu, COVID-19 and RSV.
Buffalo-based company gets $9.7M to continue vaccine development
6/25/26
Buffalo Business First reported that UB spinout company POP Biotechnologies, founded by Jonathan Lovell, will receive up to nearly $10 million to advance a vaccine candidate for the bird flu and help prepare for any future pathogen outbreak.
UB spinout POP Biotechnologies receives up to $9.7 million to advance rapid-response vaccine platform
6/11/26
UB spinout company POP Biotechnologies, co-founded by Jonathan Lovell, will receive nearly $10 million to advance a rapid-response vaccine platform.